My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 595

    1.

    Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes.

    Gaster M, Rustan AC, Beck-Nielsen H.

    Diabetes. 2005 Mar;54(3):648-56.PMID: 15734839 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes.

    Gaster M, Rustan AC, Aas V, Beck-Nielsen H.

    Diabetes. 2004 Mar;53(3):542-8.PMID: 14988236 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of beta-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid.

    Wensaas AJ, Rustan AC, Just M, Berge RK, Drevon CA, Gaster M.

    Diabetes. 2009 Mar;58(3):527-35. Epub 2008 Dec 9.PMID: 19066312 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects.

    Gaster M, Beck-Nielsen H.

    Biochim Biophys Acta. 2006 Jan;1761(1):100-10. Epub 2006 Jan 18.PMID: 16442843 [PubMed - indexed for MEDLINE]Related articles

    5.

    The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin--evidence from cultured myotubes.

    Gaster M, Beck-Nielsen H.

    Biochim Biophys Acta. 2004 Sep 6;1690(1):85-91.PMID: 15337174 [PubMed - indexed for MEDLINE]Related articles

    6.

    Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.

    Ortenblad N, Mogensen M, Petersen I, Højlund K, Levin K, Sahlin K, Beck-Nielsen H, Gaster M.

    Biochim Biophys Acta. 2005 Jun 30;1741(1-2):206-14. Epub 2005 Apr 22.PMID: 15894466 [PubMed - indexed for MEDLINE]Related articles

    7.

    Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells.

    Aas V, Rokling-Andersen MH, Kase ET, Thoresen GH, Rustan AC.

    J Lipid Res. 2006 Feb;47(2):366-74. Epub 2005 Nov 21.PMID: 16301737 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long-chain Acyl-CoA is not primarily increased in myotubes established from type 2 diabetic subjects.

    Just M, Faergeman NJ, Knudsen J, Beck-Nielsen H, Gaster M.

    Biochim Biophys Acta. 2006 Jul;1762(7):666-72. Epub 2006 May 23.PMID: 16815692 [PubMed - indexed for MEDLINE]Related articles

    9.

    The dynamic of lipid oxidation in human myotubes.

    Gaster M.

    Biochim Biophys Acta. 2009 Jan;1791(1):17-24. Epub 2008 Oct 8.PMID: 18952196 [PubMed - indexed for MEDLINE]Related articles

    10.

    Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.

    Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA, Watt MJ.

    J Appl Physiol. 2006 May;100(5):1467-74. Epub 2005 Dec 15.PMID: 16357064 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Lipid metabolism in human skeletal muscle cells: effects of palmitate and chronic hyperglycaemia.

    Aas V, Rokling-Andersen M, Wensaas AJ, Thoresen GH, Kase ET, Rustan AC.

    Acta Physiol Scand. 2005 Jan;183(1):31-41. Review.PMID: 15654918 [PubMed - indexed for MEDLINE]Related articles

    12.

    Chronic hyperglycaemia promotes lipogenesis and triacylglycerol accumulation in human skeletal muscle cells.

    Aas V, Kase ET, Solberg R, Jensen J, Rustan AC.

    Diabetologia. 2004 Aug;47(8):1452-61. Epub 2004 Jul 28.PMID: 15309295 [PubMed - indexed for MEDLINE]Related articles

    13.

    Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation.

    Perdomo G, Commerford SR, Richard AM, Adams SH, Corkey BE, O'Doherty RM, Brown NF.

    J Biol Chem. 2004 Jun 25;279(26):27177-86. Epub 2004 Apr 22.PMID: 15105415 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.

    Pimenta AS, Gaidhu MP, Habib S, So M, Fediuc S, Mirpourian M, Musheev M, Curi R, Ceddia RB.

    J Cell Physiol. 2008 Nov;217(2):478-85.PMID: 18561258 [PubMed - indexed for MEDLINE]Related articles

    15.

    Metabolic flexibility is conserved in diabetic myotubes.

    Gaster M.

    J Lipid Res. 2007 Jan;48(1):207-17. Epub 2006 Oct 24.PMID: 17062897 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.

    Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR.

    Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E354-62. Epub 2003 Apr 15.PMID: 12700163 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid.

    Sabin MA, Stewart CE, Crowne EC, Turner SJ, Hunt LP, Welsh GI, Grohmann MJ, Holly JM, Shield JP.

    J Cell Physiol. 2007 Apr;211(1):244-52.PMID: 17219404 [PubMed - indexed for MEDLINE]Related articles

    18.

    DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells.

    Montell E, Turini M, Marotta M, Roberts M, Noé V, Ciudad CJ, Macé K, Gómez-Foix AM.

    Am J Physiol Endocrinol Metab. 2001 Feb;280(2):E229-37.PMID: 11158925 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects.

    Gaster M.

    Biochem Biophys Res Commun. 2009 May 15;382(4):766-70. Epub 2009 Mar 24.PMID: 19324004 [PubMed - indexed for MEDLINE]Related articles

    20.

    Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA.

    Bell JA, Volpi E, Fujita S, Cadenas JG, Rasmussen BB.

    Diabetologia. 2006 Sep;49(9):2144-52. Epub 2006 Jul 26.PMID: 16868746 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity